Article
Perifosine enhances the potential antitumor effect of 5-fluorourasil and oxaliplatin in colon cancer cells harboring the PIK3CA mutation.
European journal of pharmacology - 5 May 2021
Morii Yusuke, Tsubaki Masanobu, Takeda Tomoya, Otubo Rie, Seki Shiori, Yamatomo Yuta, Imano Motohiro, Satou Takao, Shimomura Kazunori, Nishida Shozo
Abstract excerpt
Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) mutation in colon cancer contributes to the poor prognosis of the disease and chemoresistance of tumors. New therapies are needed; however, the lack of knowledge of the mechanism of chemoresistance has hindered progress. In this study, we investigated the mechanism of the reduced sensitivity of colon cancer cells to 5-fluorouracil...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
